ENDO 2021 Educational Sessions

November 05, 2020

ENDO 2021 offers the opportunity to hear case presentations and debates about treatments from master clinicians. The sessions listed below are a snapshot of the live master clinician and debate sessions you can expect at ENDO. To view the full listing, please visit the program planner.

Endocrine Debate: Using SGLT2 Inhibitors in Patients With T1DM

  • Moderator: Lauren H. Golden, MD, New York University Langone Medical Center
  • Pro: Andrew J. Ahmann, MD, Oregon Health and Science University
  • Con: Anne Peters, MD, University of Southern California

Genes and Surveillance for Patients and Family With Familial Pheochromocytoma and Paraganglioma Syndromes

  • Moderator: Katherine L. Nathanson, MD, University of Pennsylvania
  • Panelists: Scott A. Akker, MBBS, PhD, MRCP, St. Bartholomew's Hospital
    Roderick J. Clifton-Bligh, MBBS, PhD, FRACP, Royal North Shore Hospital
    Karel Pacak, MD, PhD, DSc, Eunice Kennedy Shriver National Institute of Child Health and Human Development

Thyroid Nodule: Whack It, Zap It, or Leave It Alone?

  • Moderator: R. Michael Tuttle, MD, Memorial Sloan Kettering Cancer Center
  • Case Presenter: Sana Ghaznavi, MD, The University of Calgary
  • Panelists: Mary C. Frates, MD, Brigham and Women's Hospital
    Chienying Liu, MD, University of California, San Francisco
    Marius N. Stan, MD, Mayo Clinic
    Julie Ann Sosa, MD, MA, University of California, San Francisco
Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.